Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System
Stereotaxis, Inc. (STXS)
US:NASDAQ Investor Relations:
ir.stereotaxis.com
Company Research
Source: GlobeNewswire
ST. LOUIS, March 06, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the Genesis RMN® System for the robotic navigation of magnetic ablation catheters to treat heart rhythm disorders. “Genesis is a leap forward in Robotic Magnetic Navigation technology,” said David Fischel, Chairman and CEO. “We are confident Genesis will have a meaningful impact on patients, physicians, and providers in Electrophysiology. Genesis is a reflection of our commitment to positively transform interventional medicine with robotics.” Tens of millions of individuals worldwide suffer from arrhythmias. When left untreated, certain arrhythmias can significantly increase the risk of stroke, heart failure, and sudden cardiac arrest. Robotic Magnetic Navigation (RMN) introduces the benefits of robotic precision a
Show less
Read more
Impact Snapshot
Event Time:
STXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STXS alerts
High impacting Stereotaxis, Inc. news events
Weekly update
A roundup of the hottest topics
STXS
News
- Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024GlobeNewswire
- Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months [Seeking Alpha]Seeking Alpha
- Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter [Yahoo! Finance]Yahoo! Finance
- Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Stereotaxis Inc (STXS) Faces Revenue Pressure Amid Strategic Transformation [Yahoo! Finance]Yahoo! Finance
STXS
Earnings
- 3/4/24 - Miss
STXS
Sec Filings
- 4/8/24 - Form DEFA14A
- 4/4/24 - Form 4
- 4/4/24 - Form DEFA14A
- STXS's page on the SEC website